Consolidated Statements of Changes in Stockholders' Equity - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Cumulative Effect, Period of Adoption, Adjusted Balance	Common Stock	Additional Paid-in Capital	Additional Paid-in Capital Cumulative Effect, Period of Adoption, Adjustment	Additional Paid-in Capital Cumulative Effect, Period of Adoption, Adjusted Balance	Accumulated Other Comprehensive Earnings (Loss)	Retained Earnings (Accumulated Deficit)	Retained Earnings (Accumulated Deficit) Cumulative Effect, Period of Adoption, Adjustment	Retained Earnings (Accumulated Deficit) Cumulative Effect, Period of Adoption, Adjusted Balance
Beginning balance (in shares) at Dec. 31, 2020				52,868,482
Beginning balance at Dec. 31, 2020	$ 744,858			$ 53	$ 409,332			$ 8,975	$ 326,498
Increase (Decrease) in Stockholders' Equity
Share-based compensation expense related to employee stock purchase plan and share-based awards	17,910				17,910
Issuance of common stock in connection with the Company’s equity award plans (in shares)				387,612
Issuance of common stock related to employee stock purchase plan and share-based awards	7,095			$ 0	7,095
Net earnings	53,424								53,424
Unrealized gain (loss) on marketable securities, net of tax	(7,436)							(7,436)
Ending balance (in shares) at Dec. 31, 2021				53,256,094
Ending balance at Dec. 31, 2021	$ 815,851	$ (15,600)	$ 800,251	$ 53	434,337	$ (56,212)	$ 378,125	1,539	379,922	$ 40,612	$ 420,534
Increase (Decrease) in Stockholders' Equity
Accounting Standards Update [Extensible List]	Accounting Standards Update 2020-06
Share-based compensation expense related to employee stock purchase plan and share-based awards	$ 17,568				17,568
Issuance of common stock in connection with the Company’s equity award plans (in shares)				997,702
Issuance of common stock related to employee stock purchase plan and share-based awards	12,423			$ 1	12,422
Net earnings	60,711								60,711
Unrealized gain (loss) on marketable securities, net of tax	(4,749)							(4,749)
Ending balance (in shares) at Dec. 31, 2022				54,253,796
Ending balance at Dec. 31, 2022	886,204			$ 54	408,115			(3,210)	481,245
Increase (Decrease) in Stockholders' Equity
Share-based compensation expense related to employee stock purchase plan and share-based awards	26,759				26,759
Issuance of common stock in connection with the Company’s equity award plans (in shares)				469,560
Issuance of common stock related to employee stock purchase plan and share-based awards	4,620			$ 1	4,619
Net earnings	1,316
Unrealized gain (loss) on marketable securities, net of tax	2,617							2,617
Ending balance (in shares) at Dec. 31, 2023				54,723,356
Ending balance at Dec. 31, 2023	$ 921,516			$ 55	$ 439,493			$ (593)	$ 482,561